Session Type
Meeting
Search Results for COP
Abstract Number: 116
Hospital Medicine 2020, Virtual Competition
Background: Syncope scores San Francisco Syncope Rule (SFSR) and Evaluation of Guidelines in Syncope Study (EGSYS)(1) are used as screening tools for predicting adverse outcomes among patient with syncope(1, 2). Surprisingly for scoring systems used for risk stratification of same clinical condition, differ significantly based on variables of importance used in calculating individual scores. An […]
Abstract Number: 119
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Previous work suggests that hospitals’ teaching status is correlated with readmission rates, cost of care, and mortality. This research has focused on conditions closely tracked by the Centers for Medicare and Medicaid Services (CMS). The extent to which hospitals’ teaching status impacts care processes for syncope has not been extensively studied. Methods: We merged […]
Abstract Number: 120
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Chronic obstructive pulmonary disease (COPD) is associated with significant morbidity, mortality, and cost with the greatest proportion incurred treating acute exacerbations of COPD (AECOPD). While guidelines recommend oral steroids for the treatment of AECOPD, parental corticosteroids are still used in the inpatient setting; such use is associated with high costs and adverse effects. The […]
Abstract Number: 123
SHM Converge 2021
Background: Studies indicate that physicians do not clean their stethoscopes regularly, and stethoscope surfaces become contaminated with bacteria. Neither the frequency with which stethoscopes deserve cleaning nor simple, practical cleaning approaches have been well-established for hospitalists or other inpatient clinicians. Our aim was to determine bacterial contamination of stethoscopes directly from a hospital doctor’s white […]
Abstract Number: 127
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Revefenacin (REV), a once-daily, long-acting muscarinic antagonist for nebulized inhalation, was recently approved for maintenance treatment of chronic obstructive pulmonary disease (COPD). We present post hoc efficacy and safety data from three phase 3 trials in patients with moderate to very severe COPD by patient subgroup (<65 y, 65–75 y, >75 y). Methods: This […]
Abstract Number: 128
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Many patients with chronic obstructive pulmonary disease (COPD) have suboptimal peak inspiratory flow rate (sPIFR) because of lung hyperinflation, hypoxemia, and muscle wasting, preventing effective use of dry powder inhalers commonly used to treat COPD. sPIFR and airflow limitation interaction may be responsible for excess symptoms in patients with COPD. Here we characterize baseline […]
Abstract Number: 129
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Chronic Obstructive Pulmonary Disease (COPD) is the third most common cause of hospital readmission within 30 days of discharge. These readmissions increase the overall healthcare cost burden. We examined the effect of early follow-up visit with patient’s primary care physician (PCP) or pulmonologist on 30-day and 1-year readmission risk. Methods: We constructed an electronic […]
Abstract Number: 132
Hospital Medicine 2020, Virtual Competition
Background: Legionella pneumophilia is typically transmitted via inhalation aerosols derived from water or soil during outbreaks or be acquired sporadically, commonly causing community-acquired or nosocomial pneumonia1,2. Death occurs through progressive respiratory failure, shock and multiorgan failure3,4. Epidemiological data for in-patient Legionella in the United States (U.S.) is lacking. The objective of the study is to […]
Abstract Number: 135
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Research suggests that COPD patients with low peak inspiratory flow rate (PIFR,
Abstract Number: 140
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: The US healthcare system is under increasing pressure to improve value and affordability. Acute care is responsible for a large proportion of overall health costs, but the complexities and pace in this environment have left an evidence gap in value-based care transformation. Novel improvement and evaluation strategies are thus needed more than ever to […]